• ABOUT US
    • Company Overview
    • Leadership
    • Company History
    • SAB, Partners & Investors
    • Contact Us
  • TECHNOLOGY & INNOVATION
    • Stem Cell Therapy
    • Drug Screening
    • Customized iPSC Banking
    • IPs & Publications
  • PIPELINE
    • Pipelines & Milestones
  • CUSTOMIZED SERVICES
    • Screening Services
    • My iCell Bank
  • NEWS & NOTICES
    • News
    • Notices & IR
EN
  • KOR
  • JP
  • About Us
    • Company Overview
    • Leadership
    • Company History
    • SAB, Partners & Investors
    • Contact Us
  • Technology & Innovation
    • Stem Cell Therapy
    • Drug Screening
    • Customized iPSC Banking
    • IPs & Publications
  • Pipeline
    • Pipelines & Milestones
  • Customized Services
    • Screening Services
    • My iCell Bank
  • News & Notices
    • News
    • Notices & IR

IPs & Publications

We present fundamental solutions for intractable neurological diseases through innovative iPSC technology.

  • Stem Cell Therapy
  • Drug Screening
  • Customized iPSC Banking
  • IPs & Publications
  • TECHNOLOGY & INNOVATION
  • IPs & Publications
Recent Publicationssince 2020
  • 1
    2020
    Cell Proliferation
    Pathological manifestation of the induced pluripotent stem cell-derived contical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation(S170F).
1 2 3
Patents
  • 2
    2015.07.02
    Registered in Republic of Korea
    Screening method for candidate drugs for Huntington's disease using induced pluripotent stem cells derived from Huntington's disease patients. (101535253)
  • 1
    2015.04.23
    Registered in Republic of Korea
    Pharmaceutical composition for the treatment of stroke comprising neural precursor cells derived from human induced pluripotent stem cells. (101516352)
1 2
Resources
  • 12
    IPBi114-A (Human induced pluripotent stem cell)
  • 11
    IPBi113-A (Human induced pluripotent stem cell)
  • 10
    IPBi111-A (Human induced pluripotent stem cell)
  • 9
    IPBi110-A (Human induced pluripotent stem cell)
  • 8
    IPBi109-A (Human induced pluripotent stem cell)
  • 7
    IPBi108-A (Human induced pluripotent stem cell)
  • 6
    IPBi107-A (Human induced pluripotent stem cell)
  • 5
    IPBi106-A (Human induced pluripotent stem cell)
  • 4
    IPBi105-A (Human induced pluripotent stem cell)
  • 3
    IPBi103-A (Human induced pluripotent stem cell)
1 2
Copyright © iPS Bio, Inc. All Rights Reserved.
-    Address.
Suites 406-409, Pangyo Innovation Lab, 80 Beon-gil 11, Geumto-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do 13453, Republic of Korea
-    Tel.
+82-31-707-6733
-    Fax.
+82-31-707-6734